These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 30411869)
1. "Preserved" glucagon secretion in fulminant type 1 diabetes. Murase-Mishiba Y; Bessho-Tachibana M; Imagawa A J Diabetes Investig; 2019 Jan; 10(1):186-187. PubMed ID: 30411869 [TBL] [Abstract][Full Text] [Related]
2. Inappropriate glucagon and GLP-1 secretion in individuals with long-standing type 1 diabetes: effects of residual C-peptide. Thivolet C; Marchand L; Chikh K Diabetologia; 2019 Apr; 62(4):593-597. PubMed ID: 30612138 [TBL] [Abstract][Full Text] [Related]
3. Beginning of a new era in glucagon research: Breakthrough by the new glucagon assay. Kawamori D J Diabetes Investig; 2020 Sep; 11(5):1123-1125. PubMed ID: 32299149 [TBL] [Abstract][Full Text] [Related]
4. [Pax4 transdifferentiates glucagon-secreting alpha cells to insulin-secreting beta endocrine pancreatic cells]. Collombat P; Mansouri A Med Sci (Paris); 2009; 25(8-9):763-5. PubMed ID: 19765395 [No Abstract] [Full Text] [Related]
5. CART is overexpressed in human type 2 diabetic islets and inhibits glucagon secretion and increases insulin secretion. Abels M; Riva M; Bennet H; Ahlqvist E; Dyachok O; Nagaraj V; Shcherbina L; Fred RG; Poon W; Sörhede-Winzell M; Fadista J; Lindqvist A; Kask L; Sathanoori R; Dekker-Nitert M; Kuhar MJ; Ahrén B; Wollheim CB; Hansson O; Tengholm A; Fex M; Renström E; Groop L; Lyssenko V; Wierup N Diabetologia; 2016 Sep; 59(9):1928-37. PubMed ID: 27338624 [TBL] [Abstract][Full Text] [Related]
6. Impaired glucagon secretion in patients with fulminant type 1 diabetes mellitus. Komada H; Hirota Y; Sakaguchi K; Okuno Y; Ogawa W; Seino S Endocrine; 2019 Mar; 63(3):476-479. PubMed ID: 30203124 [TBL] [Abstract][Full Text] [Related]
7. Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus. Vilsbøll T; Krarup T; Sonne J; Madsbad S; Vølund A; Juul AG; Holst JJ J Clin Endocrinol Metab; 2003 Jun; 88(6):2706-13. PubMed ID: 12788877 [TBL] [Abstract][Full Text] [Related]
8. Glycaemic instability correlates with a hyperglucagonaemic response in patients with type 1 diabetes without residual beta-cell function. Bessho M; Murase-Mishiba Y; Tsutsumi C; Haseda F; Imagawa A; Terasaki J; Hanafusa T Diabetes Res Clin Pract; 2013 Nov; 102(2):e38-40. PubMed ID: 24095157 [TBL] [Abstract][Full Text] [Related]
9. Mixed meal ingestion diminishes glucose excursion in comparison with glucose ingestion via several adaptive mechanisms in people with and without type 2 diabetes. Alsalim W; Tura A; Pacini G; Omar B; Bizzotto R; Mari A; Ahrén B Diabetes Obes Metab; 2016 Jan; 18(1):24-33. PubMed ID: 26354383 [TBL] [Abstract][Full Text] [Related]
10. Short-term changes in pancreatic α-cell function after the onset of fulminant type 1 diabetes. Takahashi N; Chujo D; Tsujimoto T; Kajio H J Diabetes Investig; 2018 May; 9(3):636-637. PubMed ID: 29750106 [No Abstract] [Full Text] [Related]
11. On the role of the gut in diabetic hyperglucagonaemia. Lund A Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385175 [TBL] [Abstract][Full Text] [Related]
12. The role of dysregulated glucagon secretion in type 2 diabetes. D'Alessio D Diabetes Obes Metab; 2011 Oct; 13 Suppl 1():126-32. PubMed ID: 21824266 [TBL] [Abstract][Full Text] [Related]
13. Mixed Meal and Intravenous L-Arginine Tests Both Stimulate Incretin Release Across Glucose Tolerance in Man: Lack of Correlation with β Cell Function. Ruetten H; Gebauer M; Raymond RH; Calle RA; Cobelli C; Ghosh A; Robertson RP; Shankar SS; Staten MA; Stefanovski D; Vella A; Wright K; Fryburg DA; Metab Syndr Relat Disord; 2018 Oct; 16(8):406-415. PubMed ID: 30117761 [TBL] [Abstract][Full Text] [Related]
14. cAMP signalling in insulin and glucagon secretion. Tengholm A; Gylfe E Diabetes Obes Metab; 2017 Sep; 19 Suppl 1():42-53. PubMed ID: 28466587 [TBL] [Abstract][Full Text] [Related]
15. Diabetes mellitus is associated with an increased expression of resistin in human pancreatic islet cells. Al-Salam S; Rashed H; Adeghate E Islets; 2011; 3(5):246-9. PubMed ID: 21750415 [TBL] [Abstract][Full Text] [Related]
16. Effects of meal size and composition on incretin, alpha-cell, and beta-cell responses. Rijkelijkhuizen JM; McQuarrie K; Girman CJ; Stein PP; Mari A; Holst JJ; Nijpels G; Dekker JM Metabolism; 2010 Apr; 59(4):502-11. PubMed ID: 19846181 [TBL] [Abstract][Full Text] [Related]
17. Vildagliptin reduces glucagon during hyperglycemia and sustains glucagon counterregulation during hypoglycemia in type 1 diabetes. Farngren J; Persson M; Schweizer A; Foley JE; Ahrén B J Clin Endocrinol Metab; 2012 Oct; 97(10):3799-806. PubMed ID: 22855332 [TBL] [Abstract][Full Text] [Related]
18. The clinical and hormonal (C-peptide and glucagon) profile and liability to ketoacidosis during nutritional rehabilitation in Ethiopian patients with malnutrition-related diabetes mellitus. Abdulkadir J; Mengesha B; Welde Gebriel Z; Keen H; Worku Y; Gebre P; Bekele A; Urga K; Taddesse AS Diabetologia; 1990 Apr; 33(4):222-7. PubMed ID: 2112100 [TBL] [Abstract][Full Text] [Related]